Australian-based pharmaceutical companies have begun submitting higher reimbursement prices in applications to the PBAC, with some explicitly using US list prices, while Pfizer has announced an agreement with the Trump administration "that will ensure US patients pay lower prices". …
New pricing dynamics emerging for Australia as Pfizer signs up to US 'MFN'
October 1, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
If the UK has blinked on pharmaceutical pricing, Australia might have to pay attention
October 2, 2025 - - Latest News -
Rising influenza deaths spark call for nurse-led vaccination clinics
October 1, 2025 - - Latest News -
Radiopharm Theranostics accelerates HER2 cancer trial after positive safety review
October 1, 2025 - - Australian Biotech -
dorsaVi achieves breakthrough in robotic reflex intelligence
October 1, 2025 - - Australian Biotech -
New Zealand resets medical device procurement after years of paralysis
October 1, 2025 - - Latest News -
INOVIQ publishes breakthrough data on next-generation cancer therapy
October 1, 2025 - - Australian Biotech -
Cancer vaccine collaboration lands on the Gold Coast
October 1, 2025 - - Australian Biotech